Best CT (computer tomography) doctors: TOP 517 doctors

*CURRICULUM VITAE*

*ASSOC. PROF. DR. BURAK ORHAN BORAN*  

Specialist in Neurosurgery  

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

- “Visiting Physician”, University of Southern California, Department of Neurosurgery (1998)

- “Microsurgery Training”, Gülhane Military Medical Academy, Ankara Training and Research Hospital (2003)

*WORK PLACES:*

- GATA Haydarpaşa Training Research Hospital (2002–2003)

- Dr. Lütfi Kırdar Kartal Training Research Hospital (2003–2005)

- Özel Avicenna Ataşehir Hospital (2005–2012)

- Özel 29 Mayıs Hospital (2012–2013)

- Maltepe State Hospital (2013–2018)

- Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)

- Özel Academic Hospital (2020–2022)

- Hisar Intercontinental Hospital (2022–2024)

- Özel Medipol Acıbadem Regional Hospital (2024-present)

*ADMINISTRATIVE AND ACADEMIC POSITIONS:*

- Board Member of the Society of Neurosurgeons (2006–2009)

- Emergency Service Responsibility at Maltepe State Hospital (2014–2016)

- Assistant Chief Physician at Özel Academic Hospital (2020–2021)

- Member of the Advisory Board at Beykent University Faculty of Medicine (2018–2024)

- Faculty Member at Galata University Faculty of Health Sciences (2022–2024)

- Director of the Continuous Education Center at Galata University (2022–2024)

*PUBLICATIONS IN SCIENCE CITATION INDEX AND SCI EXPANDED:*

- Guculu B, Deniz L, Yuce Y, Adilay U, Aytar H, Turkoglu M, Tiryaki M, Ozdek R, Boran BO: Transformational epidural steroid injection in the treatment of pain in foraminal and parameidan lumbar disc herniations. Turkish Neurosurgery 30: 394-399, 2020.

- Boran P, Tokuc G, Boran BO, Oktem S: Intracerebral hematoma as a complication of intrathecal methotrexate administration. Pediatric Blood & Cancer 50:152-154, 2008.

- Boran BO, Boran P, Barut N, Akgun C, Celikoglu E, Bozbuga M: Evaluation of mild head trauma in pediatric population. Pediatric Neurosurgery 42:203-207, 2006.

- Tokuc G, Boran P, Boran BO: Cleidocranial dysplasia in a mother and her daughter within the scope of neurosurgery. Journal of Neurosurgery (4 Suppl Pediatrics) 104:290-292, 2006.

- Celikoglu E, Boran BO, Bozbuga M: Abscess formation in Rathke’s cleft cyst. Neurology India 54(2):213–214, 2006.

- Bozbuga M, Boran BO, Sahinoğlu K: Surface anatomy of the posterolateral cranium regarding the localization of the initial burr-hole for retrosigmoid approach. Neurosurgical Review 29(1):61–63, 2006.

- Boran BO: Rhombencephalosynapsis: a rare cerebellar malformation. Journal of Neurological Sciences (Turkish) 23(1):46-48, 2006.

- Boran BO, Colak A, Kutlay M: Erythropoietin enhances neurological recovery after experimental spinal cord injury. Restorative Neurology and Neuroscience 23:341–345, 2005.

- Colak A, Boran BO, Kutlay M, Demircan N: A modified technique of syringosubarachnoid shunting for the treatment of syringomyelia. Journal of Clinical Neuroscience 12(6):677–679, 2005.

- Bozbuga M, Celikoğlu E, Boran BO: Hydatid cyst of the craniocervical junction: case report. Neurosurgery 57(1):193, 2005.

- Boran BO, Akgün C, Bozbuga M: Calvarial remodeling for the treatment of scaphocephaly in a 4-month-old boy: a technical note. Turkish Neurosurgery 15(1):40-44, 2005.

- Boran BO, Barut N, Akgün C, Çelikoglu E, Bozbuga M: Indications for computed tomography in patients with mild head injuries. Turkish Journal of Trauma and Emergency Surgery 11(3):218–224, 2005.

- Colak A, Kutlay M, Boran BO, Demircan N: Identical twins presenting with hydrocephalus: one with triventricular, and the other tetraventricular hydrocephalus. Turkish Journal of Medical Sciences 34:187-189, 2004.

- Kurtkaya O, Elmacı I, Boran BO, Kılıç T, Sav A, Pamir MN: Dysembryoplastic neuroepithelial tumor of the midbrain tectum: a case report. Brain Tumor Pathology 19(2):97-100, 2002.

- Elmacı I, Kurtkaya O, Boran BO, Kılıç T, Pamir MN: Gliosarcoma associated with neurofibromatosis type 1: a case report. Tumori 87:60-63, 2001.

- Boran BO, Kılıç T, Peker S, Şengöz M, Erdıvanlı B, Pamir N: Gamma-knife radiosurgery in the management of brain metastases. Turkish Neurosurgery 11:9-17, 2001.

*OTHER INTERNATIONAL PEER-REVIEWED PUBLICATIONS:*

- Boran BO, Colak A: Oculomotor nerve palsy due to compression by posterior cerebral artery: case report. Erciyes Medical Journal 29(2):164-167, 2007.

- Bozbuga M, Boran BO, Bayindir C: Tuberculoma of the cavernous sinus. The Internet Journal of Neurosurgery 2(2), 2005.

*PUBLICATIONS IN TURKISH MEDICAL INDEX:*

- Boran BO: Osteoid osteoma of the lumbar spine: case report. Fırat Medical Journal 13(1):71-73, 2008.

- Boran BO: Growing skull fracture: a case operated on eight years later. Inönü University Faculty of Medicine Journal 13(3):185-187, 2006.

- Boran BO: A case report of foot drop following vertebroplasty. Fırat Medical Journal 11(3):185-186, 2006.

- Boran BO, Kızılay G, Bozbuga M: Ventriculoperitoneal shunt dysfunction. Turkish Neurosurgery 15(2):148-151, 2005.

- Boran BO, Dağcınar A, Özek MM: Endoscopic third ventriculostomy role in Dandy-Walker malformation. Kartal Education and Research Hospital Medical Journal 15(1):11-13, 2004.

- Boran BO, Dağcınar A, Özek MM: Repeat endoscopic third ventriculostomy. Kartal Education and Research Hospital Medical Journal 15(1):31-32, 2004.

- Boran BO, Dağcınar A, Özek MM: Endoscopic third ventriculostomy in patients under one year of age. Göztepe Medical Journal 19:83-86, 2004.

Education and Expertise

Istanbul University Istanbul Faculty of Medicine - 2010

İstanbul Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital – Orthopedics and Traumatology – 2016

Work experiences

Private Family Hospital

Private Atakoy Hospital

Sancaktepe Health Center

Baltalimanı Bone Diseases Training and Research Hospital

Diyarbakir Selahaddin Eyyubi State Hospital

Subjects He Is Competent And Interested In:

Knee Calcification

Knee pain

Meniscus Tear

Knee Ligament Injuries

Carpal Tunnel Syndrome

Neck pain

Orthopedic Diseases

Shoulder Instability

Shoulder Dislocation

Shoulder pain

Meniscus

Recurrent Shoulder Dislocations

Hip and Knee Prosthesis

Thesis:

1. Mentese ST, Colak O, Gunenc YE, Tufekci K, Eren OC, Bozkurt SU. The Effect of Hyperelastic Bone Produced with Three Dimensional Bioprinter in Heterotopic Bone Formation.

Peer Reviewed Abstracts

1. Kuru P, Bilgin S, Mentese ST, Tazegul G, Ozgur S, Cilingir OT, Akakin D, Yarat A, Kasimay O. Ameliorative Effect of Chronic Moderate Exercise in Smoke Exposed or Nicotine Applied Rats From Acute Stress Nicotine Tob Res. 2014 Sep 19. pii: ntu182. (As Senior Medical Student)

2. Özdemir ZN, Tazegül G, Kuru P, Bilgin S, Menteşe ST, Erzik C, Şirvancı S, Yeğen B. Nicotine alleviates colitis-induced damage in rats via its anti-oxidative activity. Marmara Medical Journal 2014; 27: 13-20 DOI: 10.5472/MMJ.2013.03125.1 (As Senior Medical Student)

3. Özay Özkaya Mutlu, Mert Canlı, Semih Tiber Menteşe, Ahmet Dilber; Retrospective Comperative Analysis of Preoperative Lymph Node Imaging and Pathological Results in Malignant Melanoma Patients, October Antalya 2017

Peer Reviewed Posters

1. Özlem Çolak, Semih Tiber Menteşe, Özay Özkaya, Deniz Özcan; Case Report: Differentiation of Intraoral lesions, Squamous Cell Carcinoma or Pseudoepitheliamatous Hyperplasia, October 2016, Antalya, Turkey.

2. Özay Özkaya, Semih Tiber Menteşe, Özlem Çolak, İlker Üsçetin; The Effect of Staging on Survey in Malignant Melanoma, October 2016, Antalya, Turkey.

3. Özay Özkaya Mutlu, Semih Tiber Menteşe, Ahmet Dilber, Özlem Çolak; Case Report: Free Adductor Magnus Flap Reconstruction of Calcanel Defect, October 2017, Antalya, Turkey.

4. Özlem Çolak, Özay Özkaya Mutlu, Kadri Özer, S. Tiber Menteşe; Multifunctional Use of Elongated Temporoparietal Fascia Flap in Periorbital Reconstruction, October 2018, Antalya, Turkey.

5. Ayberk Akçay, Özlem Çolak, Semih Tiber Menteşe; Case Report: Superior Epigastric Artery Perforator Propellar Flap Reconstruction of Anterior Chest Wall Defect, October 2018, Antalya, Turkey.

6. Batıbey Batmacı, Harun Erbek, Semih Tiber Menteşe, Türkay Gökeri, İlker Üsçetin, Ayşin Karasoy Yeşilada; Malign Hand Tumors in the Last Five Years In Our Clinic, September 2019, Samsun, Turkey.

7. Semih Tiber Menteşe, Harun Erbek, Özlem İmren, Mert Canlı, İlker Üsçetin, Ayşin Karasoy Yeşilada; Regional Fasciectomy Treatment Results of Dupuytren’s Contracture Patients, September 2019, Samsun, Turkey.

8. Semih Tiber Menteşe, Harun Erbek, Türkay Gökeri, Özlem İmren, Mert Canlı, Ayşin Karasoy Yeşilada; The Comparison of Results of Late Term Primarily Fixed and Hunter Prosthesis Used Flexor Digitorum Profundus Injuries, September 2019, Samsun, Turkey.

9. Semih Tiber Menteşe, Özlem Çolak, Mert Canlı, İlker Üsçetin, Ayşin Karasoy Yeşilada; Extensor Indicis Proprius Transfer Supplied with Ruptured Extensor Pollicis Longus (EPL) Proximal Portion in a Patient with Recurrent EPL Rupture, September 2019, Samsun, Turkey.

10. Özlem Çolak, Mahir Gökbulut, Selman Taşkın, Tuğçe Yasak Par, Semih Tiber Menteşe, İlker Üsçetin; Lesions Prediagnosed as Vascular Tumors; September 2020, İstanbul, Turkey.

11. Özlem Çolak, Tuğçe Yasak Par, Emre Gunenc, Selman Taşkın, Semih Tiber Menteşe, İlker Üsçetin; Flap Reconstruction of Periorbital Area Zone 2 Tumor Excision Defects, September 2020, İstanbul, Turkey.

12. Özlem Çolak, Emre Gunenc, Selman Taşkın, Tuğçe Yasak Par, Semih Tiber Menteşe, İlker Üsçetin; Thoracal Wall Reconstruction in a Male Patient with Poland Syndrome, September 2020, İstanbul, Turkey.

13. Özlem Çolak, Burak Yılmaz, Semih Tiber Menteşe, Tuğçe Yasak, İlker Üsçetin; A Rare Skin Malignancy: Sebaceous Carcinoma, November 2021, Antalya, Turkey.

Oral Presentation:

1. The Effect of Apelin on Indomethacin Induced Gastric Ulcer, World Gastroenterology Subregional Meeting, November 2011, Antalya, Turkey. (As Senior Medical Student)

2. Özlem Çolak, Semih Tiber Menteşe, Özay Özkaya Mutlu, İlker Üsçetin; Case Report: 4 Different Merkel Cell Carcinoma, October 2018, Antalya, Turkey.

3. Özlem Çolak, Semih Tiber Menteşe, İlker Üsçetin, Özay Özkaya Mutlu; Our Clinical Experience, Retrospective Analysis of Gynecomastia Patients, October 2018, Antalya, Turkey.

4. Semih Tiber Menteşe, Akif Ayberk Akçay, İlker Üsçetin, Harun Erbek, Ayşin Karasoy Yeşilada; Our Approach to Congenital Hand Anomalies Between 2015-2019 Time Periods in Our Clinic, April 2019, İstanbul, Turkey.

5. Semih Tiber Menteşe, Mert Canlı, Özlem Çolak, Batıbey Batmacı, Ayşin Karasoy Yeşilada; Results of Repair Through Nerve Graft in Our Clinic in 2015-2019 Time Periods, April 2019, İstanbul, Turkey.

6. Semih Tiber Menteşe, Mert Canlı, Özlem Çolak, Harun Erbek, Ayşin Karasoy Yeşilada; The Evaluation of Long Term Results of Mallet Finger Cases Operated 2015-2019 Periods in Our Clinic, April 2019, İstanbul, Turkey.

7. Akif Ayberk Akçay, Semih Tiber Menteşe, Ayşin Karasoy Yeşilada, Özlem Çolak; The Evulation of Biomechanical and Histologic Aspects the Effect of Direct Thrombin inhibitors on Tendon Healing, September 2019, Samsun, Turkey.

8. Özlem Çolak, Harun Erbek, Tuğçe Yasak Par, Selman Taşkın, Mert Canlı, Semih Tiber Menteşe, İlker Üsçetin; Comparison of Fat Pad Transposition and Fat Graft Application After Fat Pad Resection in Transconjunctival Lower Eyelid Blepharoplasty, September 2020, İstanbul, Turkey

9. Özlem Çolak, Zeynep Öykü Gürel, Semih Tiber Menteşe, İlker Üsçetin, Mahir Gökbulut; Versatile Use of Thoracodorsal Artery Perforator Flap in Axillary Reconstruction, November 2021, Antalya, Turkey.

10. Türkay Gökeri, Tiber Menteşe, Özlem Çolak, Günay Güldoğuş, Tuğçe Yasak Par; Effects of Covid-19 Pandemics on Emergency Plastic Surgery Patiens Admission, November 2021, Antalya, Turkey.

11. Özlem Çolak, Tuğçe Yasak Par, Semih Tiber Menteşe, Zeynep Öykü Gürel, İlker Üsçetin, Mahir Gökbulut ; Retrospective Analysis of Fourniere’s Gangrene Reconstruction Patients Operated From 2010 to 2021, November 2021, Antalya, Turkey.

12. Özlem Çolak, Semih Tiber Menteşe, Günay Güldoğuş, Tuğçe Yasak Par; Foot Defect Reconstruction with a Superficial Circumflex İliac Artery Flap Including a Bony Component, November 2021, Antalya, Turkey.

13. Özlem Çolak, Semih Tiber Menteşe, Günay Güldoğuş, Ayça Ergan Şahin; Reconstruction of Wrist Dorsum with a Very Thin Flap: Superficial Circumflex İliac Artery Perforator Flap, November 2021, Antalya, Turkey.

14. Semih Tiber Menteşe, Özlem Çolak, Caner Ali İlhan, Tuğçe Yasak Par, İlker Üsçetin; An Effective Solution for Wide Abdominal Wall Defect: Free Latissimus Dorsi Flap, November 2021, Antalya, Turkey.

15. Özlem Çolak, Semih Tiber Menteşe, Caner Ali İlhan, Ayça Ergan Şahin; An Early and Higher Function Providing Reconstruction Option in Phalangeal Bony Defects, November 2021, Antalya, Turkey.

Experiences:

1. Cardiovascular Surgery Clinic, Cardiology Hospital C. I. Parhon Iaşi/ROMANIA 2010 (IFMSA Medical Student Exchange Program)

2. Gastroenterology Clinic, Hospital Clínico Universitario Lozano Blesa Zaragoza/SPAIN 2011 (IFMSA Medical Student Exchange Program)

3. Obstetrics and Gynecology Clinic, Plastic and Reconstructive Surgery Clinic, General Surgery Clinic, Sapienza University of Rome, Rome/ITALY 2012 (ERASMUS Student Exchange Program)

4. Cardiology Clinic, Herlev Hospital, Copenhagen/DENMARK 2012 (IFMSA Medical Student Exchange Program)

5. General Surgery Clinic, Hippokration General Hospital, Athens/GREECE 2012 (Observership As Medical Student)

Courses:

1. National XXXI. Basic Microsurgery Course, June 2018, Marmara University Medical Faculty, İstanbul.

2. XXVIII. Laboratory Animal Science for Researchers Course, September 2019, YUDETAM, Yeditepe University Experimental Research Center

Dr. Arye Blachar is a diagnostic radiologist with expertise in abdominal imaging, hepatic perfusion imaging, CT colonography, and body MR imaging. He focuses on imaging studies of the abdominal and pelvic organs. He has a special interest in diagnosing cancers of the liver, lung, prostate, stomach, adrenal glands, breast, and esophagus, as well as peritoneal mesothelioma.

Dr. Blachar has been recognized as one of the best teachers at Tel Aviv University Sackler School of Medicine. Forbes Israel named him one of the country's top physicians in 2021. His honors include a Certificate of Merit for research, Magna Cum Laude for his work on portal vein thrombosis, and an Editors’ Recognition Award from the European Radiology Journal.

2015 - 2015

Medipol Üniversitesi Parkinson Hastalığı ve Hareket Bozuklukları Merkezi

2009 - 2009

Medicalpark Bahçelievler Hastanesi

1999 - 2004

Medicalpark Bahçelievler Hastanesi

1997 - 2009

Amerikan Hastanesi

1997 - 1997

VKV Amerikan Hastanesi

1995 - 1995

Division of Neurosurgery, Toronto Western Hospital Research Fellow

1995 - 1995

Department of Neurosurgery, The Johns Hopkins Hospital

1995 - 1997

Toronto Western Hospital,

1994 - 1994

Division of Neurosurgery, Toronto Western Hospital

1992 - 1992

Department of Neurosurgery, University of Virginia

1992 - 1992

Department of Neurosurgery, University of Washington

1992 - 1992

İsrail Kudüs, The European Association of Neurosurgical Societies European

1991 - 1991

İspanya Zaragoz- The European Association of Neurosurgical Societies European

1990 - 1990

Glasgow, Scotland, İngiltere

1990 - 1990

Glasgow ve Edinburg, The British Council

1990 - 1990

Glasgow ve Edinburg, The British Council1994

Marmara University Institute of Health Sciences, Neurophysiology

1993

Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery

1989

Marmara University Faculty of Medicine, Neurosurgery and Neurosurgery

1983

Hacettepe University, Faculty of Medicine

1983

Hacettepe University, Faculty of Medicine

Prof. Dr. Yasef began his medical education at Istanbul University in 1973 and graduated from Istanbul University Cerrahpaşa Faculty of Medicine in 1979. He started his specialization in neurology at the same university in 1980 and became a neurologist in 1985. During his specialty training, he spent 6 months at Hacettepe University in the Neurology Department in Ankara.

After becoming a neurologist, he completed 3.5 years of obligatory government service, spending the first 1.5 years at the Iskenderun Navy Hospital and the next 2 years at Diyarbakır Social Security Hospital. He returned to Istanbul University in 1989.

Prof. Dr. Yasef worked abroad in the United States from 1990 - 1991, focusing on dementia and behavioral neurology.

In 1994, he became an Associate Professor and continued working at Istanbul University until 1999. Between 1999 - 2002, he worked at Florence Nightingale Hospital, and then at Kozyatağı Acıbadem Hospital from 2004 to 2013.

Since 2013, he has been a valuable part of the team at Florence Nightingale Hospital.

Specialties

• Dementia
• Epilepsy
• Headaches

Work Experience

• Military Service at Iskenderun Navy Hospital, 1985 - 1986
• State Service at Diyarbakır S.S.K. Hospital, 1986 - 1989
• Florence Nightingale Hospital, 1999 - 2002
• Kozyatağı Acıbadem Hospital, 2004 - 2013
• Florence Nightingale Hospital (Since 2013)

Education, Awards and Certifications

• Inter High School Project Competition, Third in Turkey, Using the activated carbon

obtained from waste batteries as ion and gas trap,Scientific and Technological

Research Council of Turkey (TUBİTAK)-2009

• Tokat Science High School – 2010

• Istanbul University School of Medicine(Graduted with distinction) – 2016

• Sarıyer State Hospital(Emergency Medicine) 2017

• Animal Research Certificate – January 2019

• Microsurgery Certificate- May 2019

• Medical statistics certificate- July 2019

• Bagcılar Research and Training Hospital, Department of Plastic, Reconstructive and

Aesthetic Surgery(Residency) 2017-2022

• Universita Campus Bio-Medico, Department of Plastic,Reconstructive and Aesthetic

Surgery Rome/Italy(Microsurgery Fellowship) 2022-

• Erzurum State Hospital,Erzurum/Turkey 2022-2024 

Medipol Acıbadem District Hospital  (Current)

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

ACADEMIC CAREER SUMMARY

Degree: Bachelor's
Field: Medicine
University: Atatürk University
Year: 2001

Degree: Master's
Field: Medicine
University: Atatürk University
Year: 2001

Specialization/Doctorate: Internal Medicine/Gastroenterology
University: İnönü University
Year: 2012

Associate Professorship: Gastroenterology
University: İnönü University
Year: 2018

Foreign Language: English, 67.5, 2007

H-index (WoS/Google): 8/10

Impact Factor: 8.1577

Key Research Work:
“Does apocynin increase liver regeneration in the partial hepatectomy model?” Yılmaz Bilgiç, Burhan Hakan Kanat, Onural ÖZHAN, Azibe YILDIZ, Zeynep AKSUNGUR, Mehmet Erman ERDEMLİ, Nigar VARDI, Yusuf TÜRKÖZ, Sami AKBULUT, Adem KÖSE, Hakan PARLAKPINAR. Turkish Journal of Medical Sciences, 2023 (53), 1-12 Q3.

Declared Project Title, Year:
K.3.6. “Investigation of the Effects of Vinpocetine in Sepsis Created by Cecal Ligation and Puncture in Rats” (Principal Investigator), 2023

International Experience:
Advanced Endoscopy Training, Anam Hospital, South Korea (3 months, 2016)
Advanced ERCP Course, Olympus Training Center, Hamburg (2017)

ADMINISTRATIVE POSITIONS

• Institution: İnönü University Turgut Özal Medical Center
  City: Malatya
  Position: Assistant Chief Physician
  Period: 2021 - 2024

Professor Drach is a specialist in oncology with a PhD from the Medical University of Vienna. He has experience in research, internal medicine, hematologic oncology, nutrition, and lifestyle in cancer. He is the Director of the Josefstadt Private Clinic in Vienna and a member of the Board of Directors of the Austrian Society of Hematology and Oncology. He has published more than 120 scientific papers and given more than 200 lectures/presentations.

Professor Dihné is a true master in understanding the subtle mechanisms of the nervous system. His professionalism is manifested in his profound knowledge of anatomy and physiology, as well as in his ability to accurately identify and effectively treat diseases that can affect both the physical and psychological state of the patient. Professor Dihné listens carefully to everyone, creating an atmosphere of trust, and based on thorough examinations and analyses, develops an individualized treatment plan. He not only has knowledge in his hands, but also the ability to feel and understand how to restore harmony in a person's body and mind, giving them back their quality of life.

Membership in societies and awards:

German Society of Physicians. 

Research Award of the Christian and Claudia Hempel Foundation for outstanding research in the field of clinical stem cell research.

Author of numerous publications in leading medical journals in Germany and Europe.

Specialization:

• neurology
• strokes
• epilepsy
• nervous system regeneration
• stem cells
• microelectrode arrays

Work experience:

2001-2004: Training at the Centre for Molecular Neurobiology in Hamburg.

2004-2011: Training at the Neurological University Clinic Düsseldorf.

2011-2013: Training at the Neurological University Hospital Tübingen and the Hertie Institute for Clinical Brain Research. 

Professor Dihne began his scientific career at the University of Düsseldorf. 

2013-2023  Professor Dihne successfully headed the Department of Neurology at the St. Lukas Klinik Solingen for 10 years.

Since 2024: Chief Physician at the Department of Neurology at the Academic Hospital Solingen.

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Dr. Séverine Iborra is the Chief Physician of the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen. Her responsibilities include obstetrics, the delivery room, the neonatal unit, and gynecology. The department also includes the Senology/Breast Clinic at the Bergisches Breast Center Solingen, led by Dr. Manuela Seifert.

Dr. Séverine Iborra is originally from France. She began her medical studies at the University of Lyon and later transferred to Albert-Ludwigs University in Freiburg, where she received her medical license in 2007. She earned her doctorate in 2008 for experimental research in molecular oncology. From August 2008 to November 2013, Dr. Iborra worked as a resident at the University Women’s Clinic in Freiburg. After passing her specialist exams in gynecology and obstetrics, she continued her career as a specialist at the same clinic. In November 2015, she moved to RWTH University Hospital Aachen as a senior physician.

At the Clinic for Gynecology and Obstetrics, under the leadership of Prof. Dr. E. Stickeler, Dr. Iborra led the obstetrics department from 2017 to 2019. Since December 2017, she was responsible for organizing education in the department, and in October 2019, she became the Managing Senior Physician and Personnel Senior Physician of the clinic, a position she held until she moved to Solingen.

In addition to her scientific work, with numerous publications and presentations at major gynecological conferences, Dr. Iborra deepened her medical specialties. She obtained certifications in oncological diagnostics and therapy from the Gynecological Oncology Working Group, as well as additional qualifications in Cervical Pathology and Colposcopy (AGCPC), Urogynecology and Pelvic Reconstructive Surgery (AGUP), and the Professional Association of Gynecologists (BVF).

In 2019, Dr. Iborra successfully completed further specialization in “Gynecological Oncology” and “Special Obstetrics and Perinatal Medicine.” She is an active member of leading German medical societies in her field, including the German Society for Gynecology and Obstetrics, the Cervical Pathology and Colposcopy Working Group, and the German Society for Prenatal and Birth Medicine.

Treatments Offered in Our Gynecology Department

• Hysteroscopy and Dilation and Curettage (D&C) for diagnostic and therapeutic purposes.
• Removal of abnormal or symptomatic ovarian findings, such as cysts, while preserving the remaining ovary.
• Oophorectomy (removal of ovaries) in cases of abnormalities or preventively when indicated.
• Myomectomy (removal of uterine fibroids) while preserving the uterus.
• Conservative treatment of fibroids: either medication or embolization performed by radiology specialists.
• Hysterectomy with or without removal of the cervix.
• Diagnosis and clarification of unclear findings in the cervix, vagina, and vulva.
• Dysplasia treatment.
• Endometriosis management.
• Cancer treatment for vulvar, vaginal, cervical, uterine, and ovarian cancers.
• Treatment for incontinence and/or pelvic organ prolapse.

Whenever possible, we offer all procedures as minimally invasive treatments using laparoscopy or the Da Vinci robotic system.

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

1997 - 2002 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Orthopedics and Traumatology

1990 - 1996 Istanbul University Cerrahpasa Faculty of Medicine

Articles he wrote and contributed to;

Clinical efficacy of peritendinous platelet-rich plasma injection in the treatment of tendinopathies: A retrospective study Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Medium and long-term effects of acetabular roof ring and Burch-Schneider anti-protusio cages in acetabular revisions in patients with acetabular bone deficiency Correspondence: Yusuf Pirinççi , Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Dimensional variables of the proximal femur in developmental adult hip dysplasia suggest that a tapered, rectangular, press-fit design may be an optimal choice for patients with Crowe type IV hips

Specialties

Limb Lenghtening 

Sports Surgery

Meniscus Tears

Anterior Cruciate Ligament Tears

Knee Prosthesis

Hip Prosthesis

Shoulder Prosthesis

Shoulder Slap Repair

Height Extension

Tumor Surgery

Foot Surgery( Hallux Valgus)

Diabetic Foot

Bone Infections (Osteomyelitis)

Membership in societies:

Expert of scientific journals 

Close co-operation with leading surgeons

Membership of the German Medical Association 

Specialities:

Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery

Minimally invasive surgery

Gastrointestinal oncology surgery

Oncological surgery

Haemorrhoids treatment

Additional clinical specialisation in minimally invasive and hernia surgery

Surgery and transplantation of the pancreas

Work Experience:

2005: Specialist in the field of surgery

2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation

2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)

2013: Specialist in visceral surgery

2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery

2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)

2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen

Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.

Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Education

• (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
• (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

• (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
• (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
• (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye